Tocris in the News

View the latest Tocris Bioscience news

2016 Articles

Tocris Announces Launch of Tocriscreen™ Plus Tocris Announces Launch of Tocriscreen™ Plus

7th November 2016

Tocris Bioscience, part of the Biotechnology division of Bio-Techne, today announced the launch of its new compound library, Tocriscreen Plus.

Tocris Relocates to a New State of the Art Facility Tocris Relocates to a New State of the Art Facility

7th March 2016

Tocris Bioscience today announced that it has relocated to a new 30,000 square foot premises located on the outskirts of Bristol, UK

2014 Articles

Tocris and SGC Collaboration Tocris and SGC Collaboration

15th October 2014

Tocris is working with the Structural Genomics Consortium (SGC) to supply novel chemical probes and compounds for epigenetics research

Introducing Bio-Techne Introducing Bio-Techne

1st July 2014

We are pleased to introduce you to Bio-Techne, the new trade name for Tocris' parent company

2012 Articles

Tocris US Office Transition Tocris US Office Transition

4th November 2012

As of January 1, 2012 all of Tocris' customer service, shipping, technical service and administrative activities are being handled by the R&D Systems Minneapolis facility.

Tocris is a Licensed Supplier of the Correct Isomer of Bosutinib Tocris is a Licensed Supplier of the Correct Isomer of Bosutinib

31st May 2012

Tocris would like to reassure the research community that the bosutinib supplied by Tocris is authentic, fully-licensed material

Tocris UK Office Transition Tocris UK Office Transition

16th April 2012

As of April 16th, 2012 all of Tocris' customer service, shipping, technical service and administrative activities are being handled by the R&D Systems Europe.

2011 Articles

Tocris Bioscience Joins R&D Systems Tocris Bioscience Joins R&D Systems

4th May 2011

Tocris Bioscience annouces that it is combining with R&D Systems, who specialise in biotechnology-based tools for cell biology research

2010 Articles

Pfizer Research Compounds Pfizer Research Compounds

15th March 2010

Tocris Bioscience announced today that it has entered into an agreement with Pfizer which will result in a wide range of Pfizer compounds being made available to the global research community

Novel Light-Sensitive Caged Compounds Novel Light-Sensitive Caged Compounds

1st March 2010

Tocris Bioscience and Columbia University have expanded their licence agreement to include two additional novel caged compounds, RuBi-Glutamate and RuBi-4AP.

Archived News Articles

2009 Articles

2008 Articles

2007 Articles

2006 Articles

2005 Articles

1970 Articles

Quick Order

Find multiple products by catalog number

divider line

Sign up to our E-Alerts

Win an iPad Air 2 or Mini 4

e-alerts

To receive the latest product news relevant to your interests, sign up to our e-alerts or update your details, and you will automatically be entered into the draw to win an iPad Air 2 or Mini 4 of your choice.

divider line

Bio-Techne Events

One Day Symposium

Bio-Techne Symposium 2017

Epigenetic Regulation of Stem Cell Differentiation

March 1, 2017

Amsterdam, The Netherlands